Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma.

Publication Title

Oncotarget

Document Type

Article

Publication Date

6-13-2024

Keywords

california; sjci; santa monica

Clinical Institute

Cancer

Specialty/Research Institute

Dermatology

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Oncology

DOI

10.18632/oncotarget.28590

Share

COinS